期刊簡介 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | DRUG RESISTANCE UPDATES LetPub Score 9.2
50 ratings
Rate
Reputation 10.0 Influence 8.5 Speed 9.6 | ||||||||||||||||||||||||||||||||
期刊簡稱 | DRUG RESIST UPDATE | ||||||||||||||||||||||||||||||||
ISSN | 1368-7646 | ||||||||||||||||||||||||||||||||
E-ISSN | 1532-2084 | ||||||||||||||||||||||||||||||||
h-index | 100 | ||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||
自引率 (2023-2024) | 4.40%自引率趨勢 | ||||||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/drug-resistance-updates/ | ||||||||||||||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||||||
出版商 | Churchill Livingstone | ||||||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||||||||||
創刊年 | 1998 | ||||||||||||||||||||||||||||||||
每年文章數 | 72每年文章數趨勢 | ||||||||||||||||||||||||||||||||
黃金OA百分比 | 40.00% | ||||||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1368-7646%5BISSN%5D | ||||||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Invited contributions ? Irregular | ||||||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[DRUG RESISTANCE UPDATES] 的評論 | 撰寫評論 |
作者: zxmine 領域: 医学 審稿時間: 5.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-09-03 18:56:23 評論於 It is indeed too slow. If you are in a hurry to graduate or in a hurry to use it, please invest cautiously.(0) 讚! | zxmine |
作者: Tomorrow's sun 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-08-06 15:36:15 評論於 Tumor, a top journal on microbial drug resistance, medical field, very professional, accepts reviews and innovative research articles, very promising.(1) 讚! | Tomorrow's sun |
作者: 白云曼萱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-06 09:27:53 評論於 So slow!!!(0) 讚! | 白云曼萱 |
作者: 削月会强 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-01 10:09:22 評論於 Research focus: tumor drug resistance Experience sharing: Too too too too too slow...(0) 讚! | 削月会强 |
作者: 一条小海之 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-28 17:28:25 評論於 Research focus: Tumor drug resistance; Experience of drug resistance: Submitted in August of 23rd year, edited for 17 days, reviewed externally for 2 and a half months, major revision for 6 months, second review for 14 days, accepted in June of 24th year.(0) 讚! | 一条小海之 |
作者: zxmine 領域: 医学 審稿時間: 5.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-06-24 15:22:03 評論於 Submitted in August 23rd, with editor for 2 weeks, it was extremely difficult to find experts for external review. A total of 46 experts were invited, with 2 rounds of review and 36 questions. Major revisions were made in November, with a 3-month extension. The revised manuscript was submitted by the end of May and received a second review in June, lasting 15 days. It has been accepted.(0) 讚! | zxmine |
作者: 绿松少女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-03 14:05:22 評論於 Excuse me, is it an article or a review? And how many reviewers are there?(0) 讚! | 绿松少女 |
作者: 削月会强 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-14 20:13:00 評論於 Wow, this is taking too much time(0) 讚! | 削月会强 |
作者: john888 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-15 15:05:35 評論於 Is it easy for senior experts to review submissions? Is it difficult to find reviewers?(0) 讚! | john888 |
作者: 中原向雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-13 19:51:48 評論於 How are you doing?(0) 讚! | 中原向雪 |
作者: 中原向雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-13 15:01:31 評論於 Did you not find the reviewer's rejection?(0) 讚! | 中原向雪 |
作者: 中原向雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-11 13:57:52 評論於 Have you received this piece of drug article?(0) 讚! | 中原向雪 |
作者: 削月以松 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-04 17:04:51 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Research focus: Antimicrobial resistance sharing experience: Previously a review journal so the impact factor is very high (>20) but the reputation is average. Starting to accept articles in 2023 (The overall quality of the articles is decent, but may not reach the top 20 level) The final stability level is still to be observed. There are suitable articles. Why not try submitting one?(0) 讚! | 削月以松 |
作者: Tomorrow's sun 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-01-17 14:38:44 評論於 The latest partition in 2024 is not from a top journal, which is indeed confusing. What's the point of changing it back and forth?(0) 讚! | Tomorrow's sun |
作者: 破戒淑琴 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-11 13:44:03 評論於 How long will it take to meet with the editor later?(0) 讚! | 破戒淑琴 |
作者: 破戒淑琴 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-09 22:58:00 評論於 Submission success rate: 25.0 Research focus: Microbial drug resistance Sharing experience: Hey friends, how long does it take for this journal submission to reach the editor with edits?(0) 讚! | 破戒淑琴 |
作者: 罗汉沈然 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-30 15:50:25 評論於 Do you have any feedback on the manuscript?(0) 讚! | 罗汉沈然 |
作者: 景焕小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-11 09:02:33 評論於 2-4 days(0) 讚! | 景焕小姐姐 |
作者: 映真郎 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-10 20:00:32 評論於 Do you have a link?(0) 讚! | 映真郎 |
作者: 金山静梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-10 10:49:03 評論於 In general, parents should listen to their children more, even if what the children are saying is not important(0) 讚! | 金山静梅 |
作者: 金山静梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-08 13:13:25 評論於 Dr. Bik is reporting Chen Zhe Sheng's peer review fraud(0) 讚! | 金山静梅 |
作者: 景焕小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-07 13:10:18 評論於 Review speed: 3.0 | Submission acceptance rate: 25.0 Emphasized research direction: drug resistance Experience sharing: Record the process for reference: After submission, waited more than 20 days for the editor's handling, waited 2 months for external review, and waited 20 days for RRC and other editor's handling, then got rejected. The editor's processing efficiency is low, and it is difficult to find expert reviewers(0) 讚! | 景焕小姐姐 |
作者: 金山静梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-06 14:35:13 評論於 Editor-in-chief Chen Zhesheng is currently being reported by Dr. Bik(0) 讚! | 金山静梅 |
作者: 天池骊颖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-03 11:26:07 評論於 How long after "with editor" will it be sent for external review?(0) 讚! | 天池骊颖 |
作者: 景焕小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-20 17:08:59 評論於 Uncertain, but it usually takes a long time to hear back from the editor, which indicates the risk of having the manuscript rejected at the initial review(0) 讚! | 景焕小姐姐 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us